NCT01637285View on ClinicalTrials.gov

A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
BIOLOGICAL

PF-04856883

Dose A

BIOLOGICAL

PF-04856883

Dose B

BIOLOGICAL

PF-04856883

Dose C

BIOLOGICAL

PF-04856883

Dose D

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY